Interspecies differences in renal localization of cyclooxygenase isoforms: implications in nonsteroidal antiinflammatory drug-related nephrotoxicity.
about
Renal papillary necrosisPhysiology of kidney reninNonsteroidal Anti-Inflammatory Drugs and the KidneyKey enzymes for renal prostaglandin synthesis: site-specific expression in rodent kidney (rat, mouse)Basic biology and clinical application of specific cyclooxygenase-2 inhibitors.Piperine inhibits the activities of platelet cytosolic phospholipase A2 and thromboxane A2 synthase without affecting cyclooxygenase-1 activity: different mechanisms of action are involved in the inhibition of platelet aggregation and macrophage infActivation of complement system in kidney after ketoprofen-induced kidney injury in sheep.Nitrooleic acid protects against cisplatin nephropathy: role of COX-2/mPGES-1/PGE2 cascade.Ameliorative effect of ocimum sanctum on meloxicam induced toxicity in wistar rats.Humanized thymidine kinase-NOG mice can be used to identify drugs that cause animal-specific hepatotoxicity: a case study with furosemide.Efficacy and safety of 3 versus 5 days of meloxicam as an analgesic for feline onychectomy and sterilization.Upregulation of cyclooxygenase-2 expression in porcine macula densa with chronic nitric oxide synthase inhibitionEffect of Cyclooxygenase(COX)-1 and COX-2 inhibition on furosemide-induced renal responses and isoform immunolocalization in the healthy cat kidney.Pulmonary and cardiorenal cyclooxygenase-1 (COX-1), -2 (COX-2), and microsomal prostaglandin E synthase-1 (mPGES-1) and -2 (mPGES-2) expression in a hypertension model.Cyclooxygenase in normal human tissues--is COX-1 really a constitutive isoform, and COX-2 an inducible isoform?The liver X receptor agonist TO901317 protects mice against cisplatin-induced kidney injury.Cyclooxygenase (COX) Inhibitors and the Newborn Kidney.Pathophysiology of cyclooxygenase inhibition in animal models.Pathophysiology of cyclooxygenases in cardiovascular homeostasis.Osteoarthritis in the cat: 2. how should it be managed and treated?Feline acute kidney injury: 1. Pathophysiology, etiology and etiology-specific management considerations.Feline hip dysplasia: A challenge to recognise and treat.Prostaglandin signaling in the renal collecting duct: release, reuptake, and oxidation in the same cell.Role of p38 in the regulation of renal cortical cyclooxygenase-2 expression by extracellular chloride.Cyclooxygenase-1 derived prostaglandins are involved in the maintenance of renal function in rats with cirrhosis and ascites.Reduction of UV-induced skin tumors in hairless mice by selective COX-2 inhibition.Expression of cyclooxygenase-2 in the macula densa of human kidney in hypertension, congestive heart failure, and diabetic nephropathy.Mineralocorticoid regulation of cyclooxygenase-2 expression in rat renal medulla.ISFM and AAFP consensus guidelines: long-term use of NSAIDs in cats.Renal effect of meloxicam versus ketoprofen in anaesthetized pseudo-normovolaemic piglets.Effect of nonsteroidal anti-inflammatory drugs with varying extent of COX-2-COX-1 selectivity on urinary sodium and potassium excretion in the rat.Cyclooxygenase-2 expression in spontaneous intestinal neoplasia of domestic dogs.
P2860
Q28194567-41DF7489-5F87-4761-B2CA-2AB3DADB0547Q28279771-C1F5C87E-65E8-4004-A50D-4010C92A508DQ28386844-24742012-0410-434B-A832-2DC858B1E824Q28583685-5962957B-4FCB-457D-8AF4-1632303CE264Q33822140-BCBE081B-5B2F-4085-A553-AB77F96054D3Q34091827-80E27C5D-7239-44EF-8DFB-83493833E089Q35186726-A5F9D86E-9792-4608-A2B5-3E92FF9616F9Q35227002-09F27DDA-A669-457B-995E-9EA05727C51BQ35245147-724F166F-849F-41F7-8413-BAF67FE7096AQ35745207-51222B9C-5985-4170-8FCE-83C112F46859Q35760587-ECB37F33-1BFF-4BB0-86D4-E63E345DABF1Q35776018-EFCF2339-3DF3-456E-BE59-C756D2675C0EQ35860447-75976B70-11FE-45F0-9EE4-3924C163A7D0Q35868746-248ABE9B-0F40-4A51-B6B3-09EC77F52C57Q35893380-F1137B89-C0C9-493E-BE0F-DF701B24C30DQ37071339-F9DF5F88-1621-4B24-A0AD-22F8AD48158CQ37277333-4A1E875F-AB7B-4985-AB8A-99352F3683C3Q37398476-CA3AB541-F74C-48F2-91F7-625440CB09A2Q37736991-72C03108-A51B-4A95-9D38-DFEA1DD39791Q37976032-47595088-5A91-4D13-BE9A-C3296ACBB560Q38054026-900C6BD1-EA8C-40B2-B766-D4BA89A75A4EQ38758657-6E94AD68-1853-4027-AA2F-022ACF819660Q40430430-AD7B019C-FE9C-46E4-8204-7D39FA513EFCQ40735274-4D9E1EBB-E848-47A4-895C-D57967071A31Q41839153-7B4D377D-9037-4005-A9EF-017354BCB87DQ42478216-DD14D24E-2FC0-4BF7-9ED8-9E6934008DDFQ43703500-C7FEE6D4-C4F7-4139-9285-0640301BAC50Q44094425-3D343F87-C7EB-468F-85EA-17E0FEF64183Q45968059-3C5B7991-5C5C-4DF1-BB94-D4D96FE811AAQ46083837-7E17AA2A-3669-43EC-9B7E-B9A6A04D681AQ46368581-50DC9081-C34F-4816-BB0B-9FF144570C93Q53388373-F59F3A82-2B2A-43FF-9D57-27E1E7D4E1E7
P2860
Interspecies differences in renal localization of cyclooxygenase isoforms: implications in nonsteroidal antiinflammatory drug-related nephrotoxicity.
description
1998 nî lūn-bûn
@nan
1998年の論文
@ja
1998年論文
@yue
1998年論文
@zh-hant
1998年論文
@zh-hk
1998年論文
@zh-mo
1998年論文
@zh-tw
1998年论文
@wuu
1998年论文
@zh
1998年论文
@zh-cn
name
Interspecies differences in re ...... y drug-related nephrotoxicity.
@en
Interspecies differences in re ...... y drug-related nephrotoxicity.
@nl
type
label
Interspecies differences in re ...... y drug-related nephrotoxicity.
@en
Interspecies differences in re ...... y drug-related nephrotoxicity.
@nl
prefLabel
Interspecies differences in re ...... y drug-related nephrotoxicity.
@en
Interspecies differences in re ...... y drug-related nephrotoxicity.
@nl
P2093
P2860
P1476
Interspecies differences in re ...... y drug-related nephrotoxicity.
@en
P2093
C M Venturini
D L Morris
J A Brassard
T J Maziasz
P2860
P304
P356
10.1177/019262339802600504
P407
P577
1998-09-01T00:00:00Z